On the public citation graph
Pharmacokinetic drug–drug interactions with methotrexate in oncology
0 signed · 126 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ajh.21218openalex-snapshot
Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib
inferredcites →https://doi.org/10.1002/cncr.20152openalex-snapshot
High‐dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma
inferredcites →https://doi.org/10.1002/pbc.23074openalex-snapshot
Polymorphisms of the SLCO1B1 gene predict methotrexate‐related toxicity in childhood acute lymphoblastic leukemia
inferredcites →https://doi.org/10.1007/bf00686028openalex-snapshot
Impact of omeprazole on the plasma clearance of methotrexate
inferredcites →https://doi.org/10.1007/s002800050949openalex-snapshot
Omeprazole does not alter plasma methotrexate clearance
inferredcites →https://doi.org/10.1007/s11096-008-9204-9openalex-snapshot
Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report
inferredcites →https://doi.org/10.1007/s12156-011-0072-5openalex-snapshot
Molecular pharmacokinetic determinants of anticancer kinase inhibitors in humans
inferredcites →https://doi.org/10.1016/j.amjmed.2009.05.031openalex-snapshot
Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination?
inferredcites →https://doi.org/10.1016/j.clpt.2006.08.013openalex-snapshot
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine
inferredcites →https://doi.org/10.1016/s0026-895x(24)05627-xopenalex-snapshot
Prediction of in Vivo Biliary Clearance from the in Vitro Transcellular Transport of Organic Anions across a Double-Transfected Madin-Darby Canine Kidney II Monolayer Expressing Both Rat Organic Anion Transporting Polypeptide 4 and Multidrug Resistance Associated Protein 2
inferredcites →https://doi.org/10.1016/s0026-895x(24)12589-8openalex-snapshot
Identification and Characterization of Human Organic Anion Transporter 3 Expressing Predominantly in the Kidney
inferredcites →https://doi.org/10.1016/s0140-6736(00)02503-4openalex-snapshot
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia
inferredcites →https://doi.org/10.1016/s0140-6736(86)90786-5openalex-snapshot
CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFEN
inferredcites →https://doi.org/10.1023/a:1006404825356openalex-snapshot
The Effect of Anticonvulsant Drugs on Blood Levels of Methotrexate
inferredcites →https://doi.org/10.1038/nrd3028openalex-snapshot
Membrane transporters in drug development
inferredcites →https://doi.org/10.1038/sj.bjc.6602337openalex-snapshot
Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure
inferredcites →https://doi.org/10.1053/gast.2001.24804openalex-snapshot
LST-2, A human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers
inferredcites →https://doi.org/10.1067/mcp.2002.121829openalex-snapshot
Changes in plasma protein binding have little clinical relevance
inferredcites →https://doi.org/10.1073/pnas.96.12.6914openalex-snapshot
MRP3, an organic anion transporter able to transport anti-cancer drugs
inferredcites →https://doi.org/10.1074/jbc.m105160200openalex-snapshot
Mutation of Trp1254 in the Multispecific Organic Anion Transporter, Multidrug Resistance Protein 2 (MRP2) (ABCC2), Alters Substrate Specificity and Results in Loss of Methotrexate Transport Activity
inferredcites →https://doi.org/10.1093/annonc/mdf021openalex-snapshot
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment
inferredcites →https://doi.org/10.1093/annonc/mdg021openalex-snapshot
High-dose methotrexate clearance following prior vancomycin administration: no significant interaction in the absence of overt renal impairment
inferredcites →https://doi.org/10.1093/jac/dkl196openalex-snapshot
Pharmacokinetic interaction between methotrexate and piperacillin/tazobactam resulting in prolonged toxic concentrations of methotrexate
inferredcites →https://doi.org/10.1093/jnci/85.7.582openalex-snapshot
Severe Interaction Between Methotrexate and a Macrolide-Like Antibiotic
inferredcites →https://doi.org/10.1093/jnci/djk130openalex-snapshot
Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
inferredcites →https://doi.org/10.1093/ndt/gfn503openalex-snapshot
Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs
inferredcites →https://doi.org/10.1097/00007691-199310000-00004openalex-snapshot
Pharmacokinetic Interaction Between High-Dose Methotrexate and Amoxycillin
inferredcites →https://doi.org/10.1097/00007691-200208000-00018openalex-snapshot
Pharmacokinetic Interaction Between High-Dose Methotrexate and Oxacillin
inferredcites →https://doi.org/10.1097/00043426-199221000-00015openalex-snapshot
Interstitial Pulmonary Disease Associated with Dyskeratosis Congenita
inferredcites →https://doi.org/10.1097/00043426-200205000-00021openalex-snapshot
Interaction Between Methotrexate and Ciprofloxacin
inferredcites →https://doi.org/10.1097/01213011-200505000-00002openalex-snapshot
A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination
inferredcites →https://doi.org/10.1111/j.1365-2125.2005.02513.xopenalex-snapshot
Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients
inferredcites →https://doi.org/10.1111/j.1365-2125.2008.03303.xopenalex-snapshot
Co‐administration of proton pump inhibitors delays elimination of plasma methotrexate in high‐dose methotrexate therapy
inferredcites →https://doi.org/10.1111/j.1365-2710.2008.00966.xopenalex-snapshot
Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data
inferredcites →https://doi.org/10.1124/dmd.106.014407openalex-snapshot
The Influence of Macrolide Antibiotics on the Uptake of Organic Anions and Drugs Mediated by OATP1B1 and OATP1B3
inferredcites →https://doi.org/10.1124/dmd.108.024315openalex-snapshot
Methotrexate Pharmacokinetics in Transgenic Mice with Liver-Specific Expression of Human Organic Anion-Transporting Polypeptide 1B1 (SLCO1B1)
inferredcites →https://doi.org/10.1124/dmd.110.036129openalex-snapshot
Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments
inferredcites →https://doi.org/10.1124/jpet.102.034330openalex-snapshot
Characterization of Methotrexate Transport and Its Drug Interactions with Human Organic Anion Transporters
inferredcites →https://doi.org/10.1124/jpet.103.061812openalex-snapshot
Quantitative Evaluation of the Drug-Drug Interactions between Methotrexate and Nonsteroidal Anti-Inflammatory Drugs in the Renal Uptake Process Based on the Contribution of Organic Anion Transporters and Reduced Folate Carrier
inferredcites →https://doi.org/10.1124/jpet.104.068536openalex-snapshot
Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil
inferredcites →https://doi.org/10.1124/jpet.106.110379openalex-snapshot
Interaction of Nonsteroidal Anti-Inflammatory Drugs with Multidrug Resistance Protein (MRP) 2/ABCC2- and MRP4/ABCC4-Mediated Methotrexate Transport
inferredcites →https://doi.org/10.1124/jpet.107.121491openalex-snapshot
Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney Slices
inferredcites →https://doi.org/10.1124/mol.66.2.330openalex-snapshot
Unexpected Mexiletine Responses of a Mutant Cardiac Na+ Channel Implicate the Selectivity Filter as a Structural Determinant of Antiarrhythmic Drug Access
inferredcites →https://doi.org/10.1136/bmj.1.6120.1097openalex-snapshot
Prolongation and enhancement of serum methotrexate concentrations by probenecid.
inferredcites →https://doi.org/10.1136/bmj.324.7352.1497openalex-snapshot
Severe myalgia from an interaction between treatments with pantoprazole and methotrexate
inferredcites →https://doi.org/10.1158/0008-5472.can-03-4062openalex-snapshot
Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles
inferredcites →https://doi.org/10.1177/106002809703101022openalex-snapshot
Delayed Elimination of Methotrexate Associated with Piperacillin Administration
inferredcites →https://doi.org/10.1200/jco.2008.20.4156openalex-snapshot
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
inferredcites →https://doi.org/10.1345/1542-6270(2000)034<1024:pibmao>2.0.co;2openalex-snapshot
Potential Interaction Between Methotrexate and Omeprazole
inferredcites →https://doi.org/10.1371/journal.pone.0018438openalex-snapshot
Uremic Toxins Inhibit Transport by Breast Cancer Resistance Protein and Multidrug Resistance Protein 4 at Clinically Relevant Concentrations
inferredcites →https://doi.org/10.3899/jrheum.090153openalex-snapshot
Methotrexate Drug Interactions in the Treatment of Rheumatoid Arthritis: A Systematic Review
inferredcites →https://doi.org/10.4081/oncol.2011.77openalex-snapshot
Molecular pharmacokinetic determinants of anticancer kinase inhibitors in humans
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4766471openalex-extracted
Synthesis and Biophysical Analysis of Porous Bi-Phase Calcium Phosphate/Gelatin-Pva Matrices Loaded with Silver Nanoparticles and Methotrexate for Osteogenic Engineering
inferred← citeshttps://doi.org/10.1002/bdd.2091openalex-snapshot
Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug–drug interactions mediated by organic anion transporter 3
inferred← citeshttps://doi.org/10.1002/cam4.5936openalex-snapshot
Effect of c o‐medications and potential risk factors of high‐dose methotrexate‐mediated acute hepatotoxicity in patients with osteosarcoma
inferred← citeshttps://doi.org/10.1002/cpt.1008openalex-snapshot
Endogenous Metabolites‐Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between SLCO1B1 SNPs and Methotrexate Toxicity
inferred← citeshttps://doi.org/10.1002/cpt.3329openalex-snapshot
Comprehensive Evaluation of OATP ‐ and BCRP ‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling
inferred← citeshttps://doi.org/10.1002/hon.2479openalex-snapshot
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?
inferred← citeshttps://doi.org/10.1002/jcph.1544openalex-snapshot
Effect of Levetiracetam on Time to High‐Dose Methotrexate Clearance in Patients With Hematologic Malignancies
inferred← citeshttps://doi.org/10.1002/pds.4555openalex-snapshot
Concomitant use of low‐dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis
inferred← citeshttps://doi.org/10.1002/phar.2516openalex-snapshot
Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma
inferred← citeshttps://doi.org/10.1007/978-3-031-12398-6_11openalex-snapshot
Therapeutic Drug Monitoring and Toxicology of Anticancer Drugs
inferred← citeshttps://doi.org/10.1007/978-3-662-46764-0_295-1openalex-snapshot
Begleittherapie bei Methotrexat
inferred← citeshttps://doi.org/10.1007/s00228-024-03642-4openalex-snapshot
Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies
inferred← citeshttps://doi.org/10.1007/s00280-015-2849-xopenalex-snapshot
Personalizing chemotherapy dosing using pharmacological methods
inferred← citeshttps://doi.org/10.1007/s00280-019-03980-6openalex-snapshot
Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia
inferred← citeshttps://doi.org/10.1007/s00296-025-05989-yopenalex-snapshot
Methotrexate-induced pancytopenia: clinical characteristics, medication errors, and outcomes in a tertiary care centre: a retrospective single-centre study
inferred← citeshttps://doi.org/10.1007/s00431-013-1933-7openalex-snapshot
Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic
inferred← citeshttps://doi.org/10.1007/s11095-026-04087-3openalex-snapshot
Regulatory Roles of Long Non-Coding RNAs in Methotrexate Pharmacology: Mechanistic and Translational Insights
inferred← citeshttps://doi.org/10.1007/s12185-021-03184-wopenalex-snapshot
Risk prediction for delayed clearance of high-dose methotrexate in pediatric hematological malignancies by machine learning
inferred← citeshttps://doi.org/10.1007/s40262-024-01392-1openalex-snapshot
Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113067openalex-snapshot
Glycolysis aggravates methotrexate toxicity by fueling RFC1-controlled intestinal absorption in rheumatic rats
inferred← citeshttps://doi.org/10.1016/j.bulcan.2014.11.001openalex-snapshot
Mécanismes des interactions pharmacocinétiques impliquant les agents anticancéreux oraux
inferred← citeshttps://doi.org/10.1016/j.ejca.2014.04.014openalex-snapshot
Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics
inferred← citeshttps://doi.org/10.1016/j.ejim.2019.07.016openalex-snapshot
Cytopenia induced by low-dose methotrexate: An analysis of 433 cases from the French pharmacovigilance database
inferred← citeshttps://doi.org/10.1016/j.heliyon.2022.e12064openalex-snapshot
Pralatrexate Mediates Effective Killing of Gemcitabine-Resistant Pancreatic Cancer: Role of mTOR/4E-BP1 Signal Pathway
inferred← citeshttps://doi.org/10.1016/j.medmal.2012.11.006openalex-snapshot
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin
inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.138329openalex-snapshot
Synthesis and biophysical characterization of porous bi-phase calcium phosphate/gelatin-PVA scaffold: Enhanced antibacterial, osteoconductivity and anticancer activity via silver nanoparticles and methotrexate incorporation
inferred← citeshttps://doi.org/10.1016/j.pharmr.2026.100132openalex-snapshot
Emerging mechanistic trends and clinical efficacy for methotrexate: Applications to inflammatory bowel disease
inferred← citeshttps://doi.org/10.1016/j.phrs.2016.05.021openalex-snapshot
Endogenous metabolites that are substrates of organic anion transporter’s (OATs) predict methotrexate clearance
inferred← citeshttps://doi.org/10.1021/acssensors.1c00749openalex-snapshot
Selection of a Structure-Switching Aptamer for the Specific Methotrexate Detection
inferred← citeshttps://doi.org/10.1038/nrclinonc.2015.204openalex-snapshot
Computational oncology — mathematical modelling of drug regimens for precision medicine
inferred← citeshttps://doi.org/10.1038/s41598-025-33039-xopenalex-snapshot
MTHFR and ABCB1 polymorphisms associated with toxicity in hematological malignancies patients receiving high dose methotrexate
inferred← citeshttps://doi.org/10.1080/08880018.2023.2168809openalex-snapshot
Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1080/10428194.2022.2074987openalex-snapshot
Toxicity associated with high-dose intravenous methotrexate for hematological malignancies
inferred← citeshttps://doi.org/10.1080/10428194.2026.2634179openalex-snapshot
Olverembatinib and high-dose methotrexate in acute lymphoblastic leukemia: delayed methotrexate clearance and increased nephrotoxicity
inferred← citeshttps://doi.org/10.1080/1120009x.2018.1544194openalex-snapshot
Calcium Channel Blockers Possibly Delay the Elimination of Plasma Methotrexate in Patients Receiving High-Dose Methotrexate Therapy
inferred← citeshttps://doi.org/10.1080/17425255.2023.2193325openalex-snapshot
A critical review of methotrexate clinical interactions: role of transporters
inferred← citeshttps://doi.org/10.1097/ftd.0000000000000381openalex-snapshot
A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity
inferred← citeshttps://doi.org/10.1097/ftd.0000000000000445openalex-snapshot
Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate
inferred← citeshttps://doi.org/10.1097/mph.0000000000000939openalex-snapshot
Concomitant Administration of High-dose Methotrexate and Low-dose Aspirin Without Any Delay in Methotrexate Clearance in a Patient With Osteosarcoma: A Case Report and Review of the Literature
inferred← citeshttps://doi.org/10.1111/1756-185x.13004openalex-snapshot
Methotrexate-induced pancytopenia: a case series of 46 patients
inferred← citeshttps://doi.org/10.1111/bcp.12326openalex-snapshot
Urinary coproporphyrin I /( I + III ) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance
inferred← citeshttps://doi.org/10.1124/dmd.114.058529openalex-snapshot
Proton Pump Inhibitors Inhibit Methotrexate Transport by Renal Basolateral Organic Anion Transporter hOAT3
inferred← citeshttps://doi.org/10.1159/000485920openalex-snapshot
Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers
inferred← citeshttps://doi.org/10.1159/000542461openalex-snapshot
Importance of Sex-Dependent Differences for Dosing Selection and Optimization of Chemotherapeutic Drugs
inferred← citeshttps://doi.org/10.1159/000543181openalex-snapshot
Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia
inferred← citeshttps://doi.org/10.1177/1078155220979048openalex-snapshot
Applications and challenges in therapeutic drug monitoring of cancer treatment: A review
inferred← citeshttps://doi.org/10.1177/10781552251340000openalex-snapshot
Predictive factors for delayed high-dose methotrexate elimination: A practical issue for diffuse large B-cell lymphoma patients
inferred← citeshttps://doi.org/10.1186/s12911-023-02248-7openalex-snapshot
Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis
inferred← citeshttps://doi.org/10.1186/s40780-026-00587-xopenalex-snapshot
Evaluation of adverse drug reactions in cancer-related settings using diverse real-world data
inferred← citeshttps://doi.org/10.1186/s43046-022-00122-7openalex-snapshot
Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
inferred← citeshttps://doi.org/10.1186/s43046-025-00324-9openalex-snapshot
Comprehensive evaluation of high dose methotrexate therapy: a retrospective observational trial
inferred← citeshttps://doi.org/10.15343/0104-7809.202145034044openalex-snapshot
Avaliação de interações medicamentosas potenciais em pacientes oncopediátricos internados
inferred← citeshttps://doi.org/10.17749/2070-4909/farmakoekonomika.2026.316openalex-snapshot
Spontaneous reports of adverse reactions to methotrexate: retrospective analysis in the Russian Federation
inferred← citeshttps://doi.org/10.2147/dddt.s545368openalex-snapshot
Population Pharmacokinetics and Covariate Analysis of Methotrexate in Pediatric Acute Lymphoblastic Leukemia
inferred← citeshttps://doi.org/10.2147/tcrm.s30135openalex-snapshot
Glucarpidase to combat toxic levels of methotrexate in patients
inferred← citeshttps://doi.org/10.21608/aeji.2017.8993openalex-snapshot
Effects of High Dose Methotrexate and Delayed Elimination on Myelotoxicity Progression in Children with Acute Lymphoblastic Leukemia
inferred← citeshttps://doi.org/10.2174/1872208315666210921095420openalex-snapshot
Finding Appropriate Signal Peptides for Secretory Production of Recombinant Glucarpidase: An In Silico Method
inferred← citeshttps://doi.org/10.2196/preprints.45175openalex-snapshot
Establishment of the predictive model for delayed metabolism of methotrexate in children with acute lymphoblastic leukemia: a retrospective study (Preprint)
inferred← citeshttps://doi.org/10.29121/granthaalayah.v9.i8.2021.4145openalex-snapshot
IMPROVEMENT OF THE MICROFLUIDIC DEVICE FOR THE GENERATION OF MONODISPERSE MICROBUBBLES AS DRUG TRANSPORT SYSTEMS
inferred← citeshttps://doi.org/10.30895/2312-7821-2024-416openalex-snapshot
Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review)
inferred← citeshttps://doi.org/10.3109/10428194.2012.737918openalex-snapshot
Delayed elimination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population
inferred← citeshttps://doi.org/10.3389/fonc.2026.1617790openalex-snapshot
Research hotspots and trends in therapeutic drug monitoring of anticancer drugs: a 1990–2024 bibliometric analysis
inferred← citeshttps://doi.org/10.3389/fped.2026.1758691openalex-snapshot
Development of a web-based machine learning model for early prediction of delayed high-dose methotrexate clearance in pediatric osteosarcoma
inferred← citeshttps://doi.org/10.3389/fphar.2021.701452openalex-snapshot
Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
inferred← citeshttps://doi.org/10.3389/fphar.2022.817673openalex-snapshot
Evaluation and Application of Population Pharmacokinetic Models for Identifying Delayed Methotrexate Elimination in Patients With Primary Central Nervous System Lymphoma
inferred← citeshttps://doi.org/10.3389/fphar.2025.1671369openalex-snapshot
Severe hematologic toxicity after low-dose methotrexate in ectopic pregnancy: role of MTHFR polymorphism and drug interaction - a case report and literature review
inferred← citeshttps://doi.org/10.3390/pharmaceutics15041283openalex-snapshot
Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
inferred← citeshttps://doi.org/10.4155/ipk-2016-0022openalex-snapshot
Clinical Pharmacokinetics of Methotrexate in Oncology
inferred← citeshttps://doi.org/10.4314/gmj.v54i1.10openalex-snapshot
Prevalence and correlates of prehypertension and hypertension among adults in Delta State, Nigeria: a cross-sectional community-based study
inferred← citeshttps://doi.org/10.4314/gmj.v54i1.9openalex-snapshot
Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error
inferred← citeshttps://doi.org/10.5937/arhfarm2001020xopenalex-snapshot
Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.26608266openalex-snapshot
Additional file 1 of Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26608269openalex-snapshot
Additional file 2 of Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.